ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 177 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $40,056 | -64.7% | 17,192 | -51.3% | 0.00% | -100.0% |
| Q4 2023 | $113,313 | -77.7% | 35,300 | -65.5% | 0.00% | -75.0% |
| Q2 2023 | $508,355 | -35.1% | 102,285 | -17.8% | 0.00% | -42.9% |
| Q4 2022 | $783,105 | -72.5% | 124,500 | -52.8% | 0.01% | -70.8% |
| Q3 2022 | $2,851,000 | +111.2% | 263,891 | +122.9% | 0.02% | +84.6% |
| Q2 2022 | $1,350,000 | +84.4% | 118,400 | +47.3% | 0.01% | +85.7% |
| Q1 2022 | $732,000 | -29.6% | 80,400 | +98.5% | 0.01% | -36.4% |
| Q3 2021 | $1,040,000 | -61.8% | 40,500 | -61.2% | 0.01% | -62.1% |
| Q2 2021 | $2,719,000 | +910.8% | 104,279 | +942.8% | 0.03% | +190.0% |
| Q4 2018 | $269,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
| Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
| TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
| Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
| Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
| Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
| HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
| Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
| Navalign, LLC | 64,428 | $961,000 | 0.38% |
| Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |